These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pharmacologic management of refractory depression. Patten SB; Lupin DA; Boucher SA; Lamarre CJ CMAJ; 1992 Feb; 146(4):483-7. PubMed ID: 1737312 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of antidepressants and thymoregulators in the long-term evolution of depression]. Pringuey D; Robert P; Giacomoni F; Talichet L; Darcourt G Encephale; 1995 Mar; 21 Spec No 2():61-70. PubMed ID: 7588182 [TBL] [Abstract][Full Text] [Related]
28. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy. Miljković BR; Pokrajac M; Timotijević I; Varagić V Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381 [TBL] [Abstract][Full Text] [Related]
29. Lithium augmentation for treatment-resistant depression in the elderly. Lafferman J; Solomon K; Ruskin P J Geriatr Psychiatry Neurol; 1988 Jan; 1(1):49-52. PubMed ID: 3150926 [TBL] [Abstract][Full Text] [Related]
30. Re: Prophylactic therapy with lithium in elderly patients with Unipolar Major Depression. Jainer AK; Soni N; Onalaja D Int J Geriatr Psychiatry; 2003 Apr; 18(4):353-4; author reply 354. PubMed ID: 12673613 [No Abstract] [Full Text] [Related]
31. Antidepressant drug therapy for bulimia: current status. Pope HG; Hudson JI J Clin Psychiatry; 1986 Jul; 47(7):339-45. PubMed ID: 3087968 [TBL] [Abstract][Full Text] [Related]
32. Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy. Okamoto H; Shimizu E; Ozawa K; Hashimoto K; Iyo M Aust N Z J Psychiatry; 2005; 39(1-2):108. PubMed ID: 15660714 [No Abstract] [Full Text] [Related]
33. Pharmacological treatment of depression. Consulting with Dr Oscar. Berber MJ Can Fam Physician; 1999 Nov; 45():2663-8. PubMed ID: 10587774 [TBL] [Abstract][Full Text] [Related]
34. [Drug discontinuation in depression]. Vanelle JM; Féline A Encephale; 1994 Apr; 20 Spec No 1():223-9. PubMed ID: 7913680 [TBL] [Abstract][Full Text] [Related]
35. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688 [TBL] [Abstract][Full Text] [Related]
36. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. Bauer M; Döpfmer S J Clin Psychopharmacol; 2000 Apr; 20(2):287. PubMed ID: 10770484 [No Abstract] [Full Text] [Related]
39. Treatment of unipolar psychotic depression: an open study of lithium addition in refractory psychotic depression. Birkenhäger TK; van den Broek WW; Wijkstra J; Bruijn JA; van Os E; Boks M; Verkes RJ; Janzing JG; Nolen WA J Clin Psychopharmacol; 2009 Oct; 29(5):513-5. PubMed ID: 19745662 [No Abstract] [Full Text] [Related]
40. The benefit of lithium carbonate adjunct in refractory depression--fact or fiction? Kantor D; McNevin S; Leichner P; Harper D; Krenn M Can J Psychiatry; 1986 Jun; 31(5):416-8. PubMed ID: 3089576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]